NCT06695767

Brief Summary

The purpose of this study is to examine the feasibility and acceptability of an online group Neuro-behavioral Therapy (NBT) with text messaging intervention for Veterans with epilepsy and major depressive disorder (MDD).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for not_applicable major-depressive-disorder

Timeline
Completed

Started Dec 2024

Shorter than P25 for not_applicable major-depressive-disorder

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 9, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 19, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

December 19, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 6, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
Last Updated

January 9, 2025

Status Verified

January 1, 2025

Enrollment Period

2 months

First QC Date

November 9, 2024

Last Update Submit

January 8, 2025

Conditions

Keywords

veterans

Outcome Measures

Primary Outcomes (5)

  • Enrollment rate

    This is defined as the number enrolled divided by the number of eligible participants screened

    post intervention (14 weeks after baseline)

  • Retention rate

    This is defined as the number completing the study/number enrolled at baseline

    post intervention (14 weeks after baseline)

  • Session attendance rate (proportion of sessions attended)

    post intervention (14 weeks after baseline)

  • Homework completion rate (proportion of homework assignments completed)

    post intervention (14 weeks after baseline)

  • User satisfaction as assessed by The Participant Satisfaction Survey

    This is a 16 item questionnaire and the first 10 questions are scored from 1( strongly disagree)to 5(strongly agree) for a maximum score of 50, higher score indicating better outcome

    post intervention (14 weeks after baseline)

Secondary Outcomes (4)

  • Change in depression as assessed by the Patient Health Questionnaire-9 (PHQ-9),

    baseline, end of session 12 (12 weeks form baseline)

  • Change in quality of Life as assessed by the Quality of Life in Epilepsy Inventory-10 (QOLIE-10)

    baseline, end of session 12(12 weeks form baseline)

  • Change resilience as assessed by the Connor-Davidson Resilience Scale (CD-RISC)

    baseline, end of session 12(12 weeks form baseline)

  • Change in efficacy in the self management of epilepsy as assessed by the Epilepsy Self-Efficacy Scale (ESES)

    baseline, end of session 12(12 weeks form baseline)

Study Arms (1)

Neurobehavioral therapy

EXPERIMENTAL
Behavioral: Neurobehavioral therapy

Interventions

Participants will receive an introduction session and 12 1-hour long online sessions once per week for a total of 12 weeks that are guided by the investigator who is trained in NBT.Participants will engage in tools to aid in assuming control over their seizures; contextualize their environment; identify moods, situations, and thoughts; train healthy communication and support seeking; understand central nervous system medications and seizures; conduct a functional behavioral analysis; learn relaxation techniques; examine external stressors and internal triggers; and prepare for life after the intervention. Participants will be asked to complete weekly homework, thought records, seizure logs that are found in their workbooks and to engage in journal entries.

Neurobehavioral therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • English speaking veterans
  • has home internet access
  • has access to and familiarity in using a computer or tablet at least weekly
  • Asymptomatic patients with chronic conditions
  • has access to a mobile device with Short Message Service (SMS) text and picture capability
  • has an active clinical diagnosis of major depressive disorder based on the International Classification of Diseases, 10th version (ICD-10)
  • has an ICD-10 diagnosis of epilepsy with at least one seizure documented within the last five years

You may not qualify if:

  • pregnancy
  • Veterans that have current suicidal ideation
  • have active psychosis; and have an ICD-10 diagnosis of psychogenic non-epileptic seizures or conversion disorder.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Michael E. DeBakey VA Medical Center

Houston, Texas, 77030, United States

RECRUITING

The University of Texas health Science Center at Houston

Houston, Texas, 77030, United States

RECRUITING

MeSH Terms

Conditions

Depressive Disorder, MajorEpilepsy

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Melissa Fadipe, MSN, APRN, FNP-C

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Melissa Fadipe, MSN, APRN, FNP-C

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Student

Study Record Dates

First Submitted

November 9, 2024

First Posted

November 19, 2024

Study Start

December 19, 2024

Primary Completion

February 6, 2025

Study Completion

April 1, 2025

Last Updated

January 9, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations